Sylvamo's Q2 Earnings Miss Confirms What the Cash Flow Already Told Us

Sylvamo's Q2 earnings miss was not a surprise to anyone watching the cash flow — it was a confirmation. Adjusted EPS of $0.03 missed consensus by $0.44, revenue of $806 million disappointed, and adjusted EBITDA fell to $60 million from $82 million a year earlier, compressing the margin from 10% to 7%. The stock has dropped roughly 31% over the past four months and sat at $37.78 after another 4% decline on the day of the report.

The market is treating this as a cyclical trough to buy. I see it differently. The free cash flow story tells a starker tale.

Free cash flow collapsed. Sylvamo generated a negative $23 million of free cash flow in the second quarter. On a trailing twelve-month basis, free cash flow stands at just $10 million — a 96% decline year over year. For context, the company's annual dividend at $0.45 per quarter works out to roughly $1.79 per share on a trailing twelve-month basis. That implies annual dividend payments well north of $100 million. Free cash flow currently covers less than 10% of those obligations. That is not a dividend safety profile. That is a dividend being funded by drawing down working capital and balance sheet reserves.

While management notes most free cash flow is typically generated in the second half of the year, the structural headwinds don't reverse on a calendar. Revenue growth is negative 11% year over year and negative 15% quarter over quarter. Gross profit growth is down nearly 23%. The business is shrinking while capex is front-loaded.

Now let's talk about the investment cycle that's draining cash. Sylvamo's 2026 capital spending guidance is $245 million, primarily directed at its Eastover mill in South Carolina. The company has already spent $110 million year to date. The woodyard modernization is operational, the paper machine optimization is scheduled for a Q4 maintenance outage, and the softwood operation is slated for Q1 2027. Management's long-term pitch is compelling on paper: once capex normalizes in 2027 and these investments materialize, they target $300 million in annual free cash flow and 15% return on invested capital.

But 2026 is a bridge year. The company is burning cash to build capacity it doesn't yet need in a market that is losing volume. Revenue is declining, margins are compressing, and the dividend payout ratio on an earnings basis sits at 70.5%. On a free cash flow basis, the payout ratio is effectively many multiples of actual cash generation. That is the crack between what the 4.74% dividend yield promises and what the business can actually afford.

From a valuation perspective, Sylvamo does look cheap. The stock trades at 6.6 times EV/EBITDA, compared to peer Graphic Packaging at 8.5 times. It's at 0.46 times sales and 1.5 times book value. The market cap is $1.5 billion with an enterprise value of $2.3 billion. Relative to peers, the discount is real. But peer discounts in paper exist for a reason. This is not a mispricing gap — it's a reflection of deteriorating unit economics.

Even if the Eastover investments deliver exactly as management projects in 2027, the company still needs the paper demand environment to stabilize or improve. The North America segment posted $63 million of adjusted EBITDA on a 15% margin, which is the best-performing region, but Latin America and Europe combined lost $3 million of adjusted EBITDA. Europe posted negative $12 million of adjusted EBITDA on a negative 6% margin. The company is also working through the termination of a supply agreement with International Paper at Riverdale, which removed roughly 7% of annual North American uncoated freesheet supply. Imports surged during a 10% global tariff window in Q2. None of this is transient noise — it's structural pressure on volume and pricing.

That said, the survival question has a clearer answer. Sylvamo is covenant-compliant as of March 2026 per its SEC filings. Fitch affirmed its BB+ rating with a stable outlook on July 29. The company has $268 million available on its $400 million revolving credit facility maturing in 2029, plus cash on the balance sheet. Total debt from the Q2 report is $964 million, with $121 million in current maturities and $843 million in long-term debt. The balance sheet is leveraged but not distressed. This is not a company that's going to default on a bad quarter. The risk is not survival — the risk is that the dividend becomes unsustainable before the investment cycle turns things around.

All things considered, Sylvamo is not the bargain the valuation multiples suggest. It's a company in a cash-burning transition year, paying a dividend it cannot fund from operations, in a declining revenue environment, with its best-case scenario dependent on investments that won't be fully operational until next year. The 6.6x EV/EBITDA multiple is cheap, but cheap without cash flow durability is not value — it's a delay mechanism that lets income investors hold a position until something forces a cut.

There are better opportunities in the broader industrial materials space where earnings actually cover the dividend and capex cycles are in the cash-gathering phase rather than the spending phase. Even if Sylvamo executes flawlessly on Eastover, the upside requires faith in two variables outside management's control: paper demand recovery and stable input costs amid ongoing energy and chemical inflation.

I would rate Sylvamo a Hold. The dividend is tempting, the valuation looks discounted, and the long-term thesis is not broken. But the cash flow trajectory says the risk/reward doesn't justify a position right now. Wait for proof that H2 delivers the turnaround management promises, or wait for the dividend to be cut and the stock to find a floor that matches its actual earnings power. Until then, there are better places to put capital.